Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A

British Journal of Clinical Pharmacology
Thor OstenfeldPhillip Jeffrey

Abstract

The primary objective was to evaluate the pharmacokinetics (PK) of the novel EP(1) antagonist GSK269984A in human volunteers after a single oral and intravenous (i.v.) microdose (100 µg). GSK269984A was administered to two groups of healthy human volunteers as a single oral (n= 5) or i.v. (n= 5) microdose (100 µg). Blood samples were collected for up to 24 h and the parent drug concentrations were measured in separated plasma using a validated high pressure liquid chromatography-tandem mass spectrometry method following solid phase extraction. Following the i.v. microdose, the geometric mean values for clearance (CL), steady-state volume of distribution (V(ss) ) and terminal elimination half-life (t(1/2) ) of GSK269984A were 9.8 l h(-1) , 62.8 l and 8.2 h. C(max) and AUC(0,∞) were 3.2 ng ml(-1) and 10.2 ng ml(-1)  h, respectively; the corresponding oral parameters were 1.8 ng ml(-1) and 9.8 ng ml(-1)  h, respectively. Absolute oral bioavailability was estimated to be 95%. These data were inconsistent with predictions of human PK based on allometric scaling of in vivo PK data from three pre-clinical species (rat, dog and monkey). For drug development programmes characterized by inconsistencies between pre-clinical in vitro metab...Continue Reading

References

Nov 1, 1986·Journal of Pharmaceutical Sciences·J Mordenti
Oct 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·K K Chan, M Gibaldi
Jan 1, 1997·Pharmacology & Therapeutics·T IwatsuboY Sugiyama
Dec 1, 1999·Neuroscience·J P SyriatowiczD J Tracey
Feb 13, 2001·The Journal of Clinical Investigation·J L StockL P Audoly
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoichi NaritomiYuichi Sugiyama
Jul 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Catherine E TrebinoLaurent Audoly
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Hannah MebaneAlan Randich
May 14, 2004·The Journal of Biological Chemistry·Daisuke KameiIchiro Kudo
May 28, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Huadong Tang, Michael Mayersohn
Oct 4, 2005·European Journal of Pain : EJP·Alex W WilsonIain P Chessell
Nov 16, 2005·Gastroenterology·Gianrico Farrugia, Robert E Kraichely
Dec 6, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Suresh K BalaniGerald T Miwa
Sep 6, 2006·Clinical Pharmacology and Therapeutics·Graham LappinR Colin Garner
Jan 24, 2007·Bioorganic & Medicinal Chemistry Letters·Stephen C McKeownRichard J Wilson
Mar 3, 2007·The Journal of Biological Chemistry·Yukihiko Sugimoto, Shuh Narumiya
Jul 25, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Huadong TangEric Fluhler
Aug 30, 2007·British Journal of Cancer·S Marchetti, J H M Schellens
Sep 7, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Naoe YamaneYuji Kumagai
May 8, 2008·Journal of Medicinal Chemistry·Richard W Friesen, Joseph Mancini
Nov 28, 2008·Bioorganic & Medicinal Chemistry Letters·Adrian HallWendy Winchester
Dec 2, 2008·Expert Opinion on Drug Metabolism & Toxicology·Graham Lappin, R Colin Garner
Jun 16, 2009·British Journal of Clinical Pharmacology·Lionel D Lewis
Jun 16, 2009·British Journal of Clinical Pharmacology·Ajay MadanHaig P Bozigian
Oct 19, 2010·Advanced Drug Delivery Reviews·Yuichi Sugiyama, Shinji Yamashita
Oct 14, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Anthony HarrisonPaul Turnpenny

Citations

Oct 3, 2015·Leukemia & Lymphoma·Pernille SvendsenHans E Johnsen
Apr 5, 2013·Expert Opinion on Drug Metabolism & Toxicology·Graham LappinTal Burt
Jul 22, 2014·British Journal of Clinical Pharmacology·Claire BeaumontMalcolm A Young
Feb 23, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Keith A RiccardiRui Li
Sep 10, 2020·Nature Reviews. Drug Discovery·Tal BurtYuichi Sugiyama
Nov 11, 2019·International Journal of Molecular Sciences·Joong Hyun Shim
Nov 4, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yi-An BiManthena V S Varma

Related Concepts

GSK269984A
Teens
Metazoa
Anthropoidea
Biological Availability
Liquid Chromatography
Canis familiaris
Dose-Response Relationship, Drug
Drug Evaluation
Half-Life

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Incretins

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.